Quick Summary
Coleus (Plectranthus barbatus) is a plant under research for various pharmacological properties. It contains bioactive compounds such as diterpenoids (notably forskolin) and essential oils that have demonstrated antimicrobial, antioxidant, and immunomodulatory activities in preclinical studies. Clinical evidence regarding its efficacy and safety is limited and inconclusive, and further research is necessary.
What is it
Coleus, scientifically known as Plectranthus barbatus, is a botanical species belonging to the Lamiaceae family. It is commonly studied for its bioactive constituents, particularly forskolin, a diterpenoid compound found in its root extracts. The plant has been traditionally used in various cultures and is now gaining interest for potential therapeutic properties.
Traditional Uses
Coleus has a history of traditional use in different regions, including applications related to reproductive health, such as treatment of sexual dysfunction, infertility, and improving virility, especially within East African communities. Additionally, some ethnobotanical reports mention its use in managing infections and other health conditions. However, these traditional uses are not yet validated by robust clinical research.
Active Compounds
- Forskolin: A diterpene that is primarily studied for its pharmacological roles.
- Essential oils: Contributing to antimicrobial and antioxidant effects.
- Other diterpenoids and phytochemicals associated with potential health activities.
Potential Benefits with Evidence Levels
- Potential antimicrobial activity (Preclinical evidence): Essential oils and extracts from Coleus have demonstrated inhibitory effects against certain bacteria in laboratory (in vitro) studies.
- Immunomodulatory effects (Preclinical evidence): Forskolin has shown immunomodulatory properties and improved outcomes in animal disease models.
- Weight management support (Limited clinical evidence): Forskolin-containing supplements have been studied in clinical trials in Japan for anti-obesity effects; however, the data are insufficient to draw firm conclusions.
- Potential application in glaucoma and neuroprotection (Research pending): Nutraceutical formulations containing forskolin-related compounds are being investigated for neuroprotective benefits, though direct clinical evidence for Coleus is lacking.
Side Effects
Currently, no well-documented adverse effects specific to Coleus or forskolin supplements have been established in clinical settings. However, adverse events generally associated with herbal supplements warrant caution. The safety profile of Coleus and its extracts is not well characterized due to limited human studies.
Drug Interactions
No specific drug interaction data for Coleus are available. Nonetheless, some herbal compounds can modulate cytochrome P450 enzymes such as CYP3A4, which may affect the metabolism of certain drugs (e.g., statins, antidiabetic medications). Therefore, caution is advised when combining Coleus with medications metabolized by these pathways.
Who Should Avoid It
- Pregnant or breastfeeding women, due to insufficient safety data and recommended avoidance until further studies are conducted.
- Individuals taking medications metabolized by CYP3A4 or other cytochrome P450 enzymes, should consult a healthcare professional before use.
- People with known sensitivities or allergies to herbal supplements should exercise caution.
Evidence Limitations
The current evidence for Plectranthus barbatus is primarily derived from in vitro and animal studies, with very limited and low-quality clinical trial data. There are no systematic reviews or high-quality randomized controlled trials that directly assess its efficacy or safety in humans. Important aspects such as pharmacokinetics, dose-response relationships, long-term effects, and detailed drug interactions remain largely unexplored.
References
- Hui F, Williams PA. Vitamins and nutraceuticals in glaucoma research. Europe PMC, 2026. Discusses nutraceuticals including compounds relevant to Plectranthus barbatus in neuroprotection research; no direct clinical trials on Coleus.
- Hernández-Lorca M et al. Dietary Modulation of CYP3A4 and Its Impact on Statins and Antidiabetic Drugs: A Narrative Review. Europe PMC, 2025. Reviews dietary compounds affecting CYP3A4, relevant for herb-drug interactions involving herbal products.
- Yang Q et al. Butyrate, Forskolin, and Lactose Synergistically Enhance Disease Resistance by Inducing the Expression of the Genes Involved in Innate Host Defense and Barrier Function. Europe PMC, 2021. Demonstrates immunomodulatory effects of forskolin in animal infection models.
- Yasueda A, Ito T, Maeda K. Review: Evidence-based Clinical Research of Anti-obesity Supplements in Japan. Europe PMC, 2013. Identifies forskolin-containing supplements tested in clinical trials for weight loss; limited evidence.
- Unspecified. Antimicrobial activity of Plectranthus barbatus (Lamiacea). Europe PMC, 2014. Reports in vitro antimicrobial effects of Plectranthus barbatus extracts.
- Unspecified. A comprehensive review of antimalarial medicinal plants used by Tanzanians. OpenAlex, 2024. Mentions Plectranthus species in traditional medicinal uses; no direct clinical evidence.
- Kyarimpa C et al. Medicinal Plants Used in the Treatment of Sexual Dysfunction, Infertility and Improving Virility in the East African Community: A Systematic Review. Europe PMC, 2023. Ethnobotanical data suggesting traditional uses related to reproductive health; no clinical trials.
Last Reviewed
June 2024
Disclaimer: This information is provided for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before using herbal supplements, especially if you have existing health conditions or are taking medications.